To our knowledge, no other work studied the effects of ketamine on NMDA receptor subunits 5 weeks post its injection in adults; further work is needed to validate our observation of long-lasting reduction of prefrontal NR2A mRNA levels, which can have important medical implication for the use of ketamine for the treatment of depression. This evidence concerns the gene GRIN2A and depressive symptom measurement.